Janssen’s diabetes drug Invokana recommended
January 11, 2013Sales and Marketing Janssen, SGLT2, canagliflozin, diabetes, invokana
An FDA advisory committee has recommended Janssen’s new diabetes treatment canagliflozin for approval. To be marketed under the name Invokana, …
EU submission for GSK and Theravance COPD drug
January 11, 2013Sales and Marketing COPD, GSK, Theravance, UMEC/VI
GlaxoSmithKline and Theravance have submitted their chronic obstructive pulmonary disease (COPD) drug UMEC/VI to European regulators. The application follows the …
Lundbeck appoints new global pricing and market access VP
January 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eggert, Jaszewski, Lundbeck
Barbara Jaszewski, has been appointed vice president of global pricing and market access at Lundbeck. She will be in charge …
Public health budget ring-fenced
January 11, 2013Sales and Marketing Hunt, NHS, government
Local authorities are to receive a total of £5.45 billion from the government over the next two years to spend …
Cherwell appoints product specialist
January 11, 2013Manufacturing and Production, Research and Development, Sales and Marketing Cherwell Laboratories
Pharma supplier firm Cherwell Laboratories has announced the appointment of Abdulmajeed Raji as microbiology product specialist. Prior to joining Cherwell, …
FDA vote on J&J diabetes drug
January 10, 2013Sales and Marketing EU, FDA, J&J, JJ, Janssen, canagliflozin
Key advisers to the FDA are meeting today to decide whether Janssen Pharmaceuticals’ type II diabetes drug canagliflozin is safe …
Hookipa Biotech hires two officers
January 10, 2013Manufacturing and Production, Research and Development, Sales and Marketing Farshad Guirakhoo, Hookipa, Thomas Monarth
Vaccines biotech firm Hookipa Biotech AG has appointed two new members to its management team. Thomas Monath (pictured) joins as …
Global agency network welcomes new members
January 10, 2013Medical Communications Indigenus, Lindh & Partners, PharMa International
A global network of independent healthcare agencies has welcomed two new members to the group. Tokyo-based PharMa International and Swedish …
£120m health research boost
January 10, 2013Sales and Marketing Hunt, NHS, NIHR, TXA
The Department of Health is putting £120 million of new funding into health research over the next five years in …
CQC ‘needs urgent overhaul’, say MPs
January 9, 2013Sales and Marketing CQQ, Dorrell, NHS, select committee
England’s health and social care regulator, the Care Quality Commission (CQC), must overhaul its governance structures ‘as a matter of …
Gilead licences MacroGenics technology
January 9, 2013Research and Development, Sales and Marketing DART, Gilead, MacroGenics
Private biotech company MacroGenics has licenced its bi-specific antibody platform technology to Gilead Sciences for products aimed at four unnamed …
MAPI Group hires James Karis as chief executive
January 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing James Karis, MAPI
Healthcare services group MAPI has named James Karis as its chief executive. MAPI looks to Karis to consolidate its success …
SHL to present & exhibit at 10th Annual BIO Asia International Conference
January 9, 2013Manufacturing and Production auto injector, autoinjector, shl events
SHL will be presenting and exhibiting at the upcoming 10th Annual BIO Asia International Conference from January 29-30th in Tokyo, …
Private equity firm pays $195m for contract manufacturer JHP
January 8, 2013Manufacturing and Production CMO, JHP, Warburg Pincus
Private equity group Warburg Pincus has acquired sterile injectable drug manufacturer JHP Pharmaceuticals from its current owner Morgan Stanley. The …
Questcor buys API specialist BioVectra for $51m
January 8, 2013Manufacturing and Production API, Achtar, BioVectra, Questcor
US biopharma firm Questcor has signed a deal to acquire Canadian active pharmaceutical ingredient (API) manufacturer BioVectra for an upfront …
Boehringer hands back Lilly drug
January 8, 2013Research and Development, Sales and Marketing Boehringer, Tradjenta, diabetes, lilly
Boehringer Ingelheim has handed back one of Eli Lilly’s investigational diabetes drugs as a result of ‘independent strategic portfolio considerations’. …
Valeant shuts plant in Brazil, second to follow
January 8, 2013Manufacturing and Production Brazil, Medicis, Valeant
Canadian firm Valeant Pharmaceuticals has closed down one of its facilities in Brazil and will shutter a second in the …
Eisai and Novartis part ways
January 8, 2013Sales and Marketing COPD, Eisai, Novartis, Onbrez, Spiriva
Novartis and Eisai have abandoned their co-promotion agreement for three of Novartis’ chronic obstructive pulmonary disease treatments. The move follows …
Novo Nordisk appoints Curtis Oltmans to US executive team
January 8, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Oltmans
Novo Nordisk has announced that Curtis Oltmans has been promoted to corporate vice president and general counsel, Legal and Quality …
Marketing excellence: how to win over your internal audience
January 7, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Manastersky, marketing
You’ve spent months building a marketing excellence training curriculum which has been prioritised by marketing leadership as a critically important …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
